Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study. (3rd October 2018)
- Record Type:
- Journal Article
- Title:
- Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study. (3rd October 2018)
- Main Title:
- Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study
- Authors:
- Pervez, Mohammad Osman
Winther, Jacob A.
Brynildsen, Jon
Strand, Heidi
Christensen, Geir
Høiseth, Arne Didrik
Myhre, Peder L.
Røysland, Ragnhild
Lyngbakken, Magnus Nakrem
Omland, Torbjørn
Røsjø, Helge - Abstract:
- Abstract: Purpose: To compare the diagnostic and prognostic value of mid-regional pro-ANP (MR-proANP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute dyspnea. Methods: MR-proANP and NT-proBNP were measured with commercial immunoassays at hospital admission ( n = 313), on day 2 ( n = 234), and before discharge ( n = 91) and compared for diagnosing acute heart failure (HF; n = 143) and to predict mortality among patients with acute HF and acute exacerbation of chronic obstructive pulmonary disease (AECOPD; n = 84) separately. Results: The correlation coefficient between MR-proANP and NT-proBNP was 0.89 ( p < 0.001) and the receiver-operating area under the curve (AUC) was 0.85 (95% CI 0.81–0.89) for MR-proANP and 0.86 (0.82–0.90) for NT-proBNP to diagnose acute HF. During a median follow-up of 816 days, mortality rates were 46% in acute HF patients and 42% in AECOPD patients. After adjustment for other risk variables by multivariate Cox regression analysis, MR-proANP and NT-proBNP concentrations were associated with mortality in patients with acute HF, but only MR-proANP were associated with mortality among patients with AECOPD: hazard ratio (ln MR-proANP) 1.98 (95% CI 1.17–3.34). Conclusion: MR-proANP and NT-proBNP concentrations provide similar diagnostic and prognostic information in patients with acute HF. In contrast to NT-proBNP, MR-proANP measurements also provided independent prognostic information in AECOPD patients.
- Is Part Of:
- Biomarkers. Volume 23:Number 7(2018)
- Journal:
- Biomarkers
- Issue:
- Volume 23:Number 7(2018)
- Issue Display:
- Volume 23, Issue 7 (2018)
- Year:
- 2018
- Volume:
- 23
- Issue:
- 7
- Issue Sort Value:
- 2018-0023-0007-0000
- Page Start:
- 654
- Page End:
- 663
- Publication Date:
- 2018-10-03
- Subjects:
- MR-proANP -- NT-proBNP -- biomarker -- COPD -- heart failure -- prognosis
Biochemical markers -- Periodicals
610.28 - Journal URLs:
- http://informahealthcare.com/journal/bmk ↗
http://informahealthcare.com ↗
http://www.tandf.co.uk/journals/alphalist.html ↗ - DOI:
- 10.1080/1354750X.2018.1474258 ↗
- Languages:
- English
- ISSNs:
- 1354-750X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.704500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 8493.xml